Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?
We read with interest the paper of Graef et al recently published in your journal about the situation resulting from the massive use of antimalarials for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19), despite the fact that the evidence is controversial and there are concerns...
- Autores:
-
Santos Moreno, Pedro
Buitrago García, Diana
Villarreal, Laura
Aza, Anggie
Cabrera, Michael
Rivero, Wilberto
Rojas Villarraga, Adriana
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Fundación Universitaria de Ciencias de la Salud - FUCS
- Repositorio:
- Repositorio Digital Institucional ReDi
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.fucsalud.edu.co:001/1848
- Acceso en línea:
- https://repositorio.fucsalud.edu.co/handle/001/1848
- Palabra clave:
- Antimalaricos
Enfermedad cardiovascular
Artritis reumatoide
Eventos adversos
Reacciones a los antipalúdicos
COVID-19
Enfermedades cardiovasculares
Efectos colaterales y reacciones adversas relacionados con medicamentos
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)